For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.

1 April 2011
Breast cancer is the most common form of cancer among women in Australia. While most cases are sporadic, 5–10% of affected women have a strong family history of breast cancer. For most of these women, the cause of breast cancer is unknown, but some women have a mutation in a gene that increases the risk of breast cancer.
Writing in the latest edition of Australian Prescriber, Dr Chiyan Lau and Dr Graeme Suthers of SA Pathology in Adelaide weigh up the pros and cons of genetic testing for breast cancer.
“There are two commonly identified mutations, which together are found in approximately 1–2% of all breast cancers. However, women with familial breast or ovarian cancer should not necessarily undergo genetic testing for these mutations, as the majority do not have these genetic mutations.”
They warn that analysis of these genes is complex and expensive, and is often not justified. Similarly, genetic testing of an unaffected person is generally not recommended unless one of the mutations has already been identified in a family member.
“It’s important that counselling is provided before and after a genetic test, and the care of someone with the mutation is individualised.”
“The absence of an identified mutation in an affected woman does not exclude familial breast cancer. However, once a mutation has been identified in the family, a normal test result means that the person has not inherited the family's predisposition to develop cancer and does not require special cancer surveillance,” they conclude.
To read the full article and more visit www.australianprescriber.com
END
Australian Prescriber is an independent peer-reviewed journal providing critical commentary on therapeutic topics for health professionals, particularly doctors in general practice. It is published by NPS, an independent, not-for-profit organisation for quality use of medicines funded by the Australian Government Department of Health and Ageing. Australian Prescriber is published every two months, in hard copy that is distributed to health professionals free of charge, and online in full text at www.australianprescriber.com
Media enquiries
Contact us
Date published: 2011-04-01 19:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.